Provectus Pharmatech, Inc.
Records under this name other than the patents Provectus Pharmatech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Back to Provectus Pharmatech, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,422,260 | Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one(Rose Bengal) and related xanthenes Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,839,688 | Combination of Rose Bengal and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 11,426,379 | Combination of Local and Systemic Therapies for Enhanced Treatment of Dermatologic Conditions Formerly held In force · High confidence | In force | High confidence | |
| US 11,938,182 | Halogenated Xanthenes as Vaccine Adjuvants Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,975,106 | Uses of Halogenated Xanthenes in Oncology and Virology Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,470,296 | Intracorporeal medicaments for high energy phototherapeutic treatment of disease Lapsed on the fee record Ended Jun 25, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 25, 2021 | From the USPTO record |
| US 7,427,389 | Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes Lapsed on the fee record Ended Sep 23, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 23, 2020 | From the USPTO record |
| US 7,338,652 | Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents Lapsed on the fee record Ended Mar 4, 2020 · From the USPTO record | Lapsed on the fee record | Ended Mar 4, 2020 | From the USPTO record |
| US 8,974,363 | Topical medicaments and methods for photodynamic treatment of disease Term ended Term ended Dec 2, 2019 · From the USPTO record | Term ended | Term ended Dec 2, 2019 | From the USPTO record |
| US 6,986,740 | Ultrasound contrast using halogenated xanthenes Formerly held Term ended Term ended Aug 3, 2019 · From the USPTO record | Term ended | Term ended Aug 3, 2019 | From the USPTO record |